Clinical Trial Update: Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating transarterial chemoembolization with doxorubicin-eluting beads with or without sorafenib for unresectable hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin beads (doxorubicin)
• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: University College, London | Conditions: Liver Cancer | Phase 3 | Status: UNKNOWN